Financial News
ODD Investors Have Opportunity to Lead ODDITY Tech Ltd. Securities Fraud Lawsuit
NEW YORK, March 25, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of ODDITY Tech Ltd. (NASDAQ: ODD) between February 26, 2025 and February 24, 2026, inclusive (the "Class Period"). A...
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
704 articles
📰
Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update
-Advancing zervimesine clinical development in DLB psychosis – - Meeting with FDA Division of Psychiatry expected by mid-2026 -- Management...
📰
Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update
-Advancing zervimesine clinical development in DLB psychosis – - Meeting with FDA Division of Psychiatry expected by mid-2026 -- Management...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell
• ProShares UltraShort Russell2000 (NYSE:TWM) is likely to report earnings for its fourth quarter.
• MapLight...
📰
MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
SAN FRANCISCO and BOSTON, March 26, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company...
📰
Upstream Bio Highlights Phase 3 Development Strategy for Verekitug and Reports Fourth Quarter and Full Year 2025 Financial Results
– Company to pursue Phase 3 development strategy designed to deliver best-in-class efficacy with a high-dose quarterly regimen in broad patient...
📰
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"...
📰
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights
NEWTON, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage...
📰
Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain
Intranasal oxytocin blocks the release of calcitonin gene-related peptide (CGRP) in animal models and is the core technology of TNX-1900 for...
📰
Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer
-- Site Transfer Agreement for the Manufacture of Commercially Marketed Product --
-- Second Agreement Supports the Expansion of Product Commercially...
📰
Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer
Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer
📰
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update
BETHESDA, Md., March 26, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
📰
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"...
📰
Agomab Receives U.S. Patent for AGMB-447, its Inhaled Lung-restricted Small Molecule Inhibitor of ALK5 in Development for the Treatment of Idiopathic Pulmonary Fibrosis
Agomab today announced that the USPTO granted a patent covering the composition of matter of AGMB-447.
📰
Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance
RALEIGH, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging...
Elizabeth Warren Slams Big Tech–Heavy AI Council As Lisa Su, Michael Dell, Others Thank Trump: 'Only Money Gets A Seat At The Table'
On Wednesday, President Donald Trump's newly appointed AI advisory council drew reactions, with top tech executives expressing gratitude while...
Owlet, Inc. (NYSE:OWLT) Receives Average Rating of “Hold” from Analysts
Owlet, Inc. (NYSE:OWLT – Get Free Report) has been assigned a consensus rating of “Hold” from the five analysts that are presently...
Zenas BioPharma, Inc. (NASDAQ:ZBIO) Receives Average Recommendation of “Hold” from Analysts
Zenas BioPharma, Inc. (NASDAQ:ZBIO – Get Free Report) has received a consensus recommendation of “Hold” from the nine research...
📰
OptimizeRx (OPRX) Soars 5.9%: Is Further Upside Left in the Stock?
OptimizeRx (OPRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate...
Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO) Receives Average Recommendation of “Hold” from Brokerages
Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO – Get Free Report) has earned a consensus recommendation of “Hold”...
Community Health Systems, Inc. (NYSE:CYH) Receives Consensus Rating of “Hold” from Analysts
Shares of Community Health Systems, Inc. (NYSE:CYH – Get Free Report) have received an average recommendation of “Hold” from the...
Head-To-Head Survey: Omada Health (NASDAQ:OMDA) versus Charles River Laboratories International (NYSE:CRL)
Charles River Laboratories International (NYSE:CRL – Get Free Report) and Omada Health (NASDAQ:OMDA – Get Free Report) are both medical...
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine...
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Recommendation of “Hold” from Brokerages
Shares of Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) have been assigned an average rating of “Hold” from the nine...
Pharmaceutical Stocks To Watch Today – March 24th
Eli Lilly and Company, Abbott Laboratories, and Pfizer are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock...